2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Who Smokes in Europe? Data From 12 European Countries in the TackSHS Survey (2017–2018)

      research-article
      1 , 1 , 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 5 , 7 , 18 , 8 , 9 , 10 , 19 , 20 , 21 , 22 , 23 , 24 , 3 , 11 , 17 , 25 , 24 , 26 , 14 , 15 , 17 , 2 , 2 , 2 , 27 , 14 , 15 , 16 , 17 , the TackSHS Project Investigators
      Journal of Epidemiology
      Japan Epidemiological Association
      tobacco, cigarette smoking, smoking prevalence, cross-sectional study, survey, Europe, TackSHS

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Population data on tobacco use and its determinants require continuous monitoring and careful inter-country comparison. We aimed to provide the most up-to-date estimates on tobacco smoking from a large cross-sectional survey, conducted in selected European countries.

          Methods

          Within the TackSHS Project, a face-to-face survey on smoking was conducted in 2017–2018 in 12 countries: Bulgaria, England, France, Germany, Greece, Ireland, Italy, Latvia, Poland, Portugal, Romania, and Spain, representing around 80% of the 432 million European Union (EU) adult population. In each country, a representative sample of around 1,000 subjects aged 15 years and older was interviewed, for a total of 11,902 participants.

          Results

          Overall, 25.9% of participants were current smokers (31.0% of men and 21.2% of women, P < 0.001), while 16.5% were former smokers. Smoking prevalence ranged from 18.9% in Italy to 37.0% in Bulgaria. It decreased with increasing age (compared to <45, multivariable odds ratio [OR] for ≥65 year, 0.31; 95% confidence interval [CI], 0.27–0.36), level of education (OR for low vs high, 1.32; 95% CI, 1.17–1.48) and self-rated household economic level (OR for low vs high, 2.05; 95% CI, 1.74–2.42). The same patterns were found in both sexes.

          Conclusions

          These smoking prevalence estimates represent the most up-to-date evidence in Europe. From them, it can be derived that there are more than 112 million current smokers in the EU-28. Lower socio-economic status is a major determinant of smoking habit in both sexes.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015

          Summary Background The scale-up of tobacco control, especially after the adoption of the Framework Convention for Tobacco Control, is a major public health success story. Nonetheless, smoking remains a leading risk for early death and disability worldwide, and therefore continues to require sustained political commitment. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) offers a robust platform through which global, regional, and national progress toward achieving smoking-related targets can be assessed. Methods We synthesised 2818 data sources with spatiotemporal Gaussian process regression and produced estimates of daily smoking prevalence by sex, age group, and year for 195 countries and territories from 1990 to 2015. We analysed 38 risk-outcome pairs to generate estimates of smoking-attributable mortality and disease burden, as measured by disability-adjusted life-years (DALYs). We then performed a cohort analysis of smoking prevalence by birth-year cohort to better understand temporal age patterns in smoking. We also did a decomposition analysis, in which we parsed out changes in all-cause smoking-attributable DALYs due to changes in population growth, population ageing, smoking prevalence, and risk-deleted DALY rates. Finally, we explored results by level of development using the Socio-demographic Index (SDI). Findings Worldwide, the age-standardised prevalence of daily smoking was 25·0% (95% uncertainty interval [UI] 24·2–25·7) for men and 5·4% (5·1–5·7) for women, representing 28·4% (25·8–31·1) and 34·4% (29·4–38·6) reductions, respectively, since 1990. A greater percentage of countries and territories achieved significant annualised rates of decline in smoking prevalence from 1990 to 2005 than in between 2005 and 2015; however, only four countries had significant annualised increases in smoking prevalence between 2005 and 2015 (Congo [Brazzaville] and Azerbaijan for men and Kuwait and Timor-Leste for women). In 2015, 11·5% of global deaths (6·4 million [95% UI 5·7–7·0 million]) were attributable to smoking worldwide, of which 52·2% took place in four countries (China, India, the USA, and Russia). Smoking was ranked among the five leading risk factors by DALYs in 109 countries and territories in 2015, rising from 88 geographies in 1990. In terms of birth cohorts, male smoking prevalence followed similar age patterns across levels of SDI, whereas much more heterogeneity was found in age patterns for female smokers by level of development. While smoking prevalence and risk-deleted DALY rates mostly decreased by sex and SDI quintile, population growth, population ageing, or a combination of both, drove rises in overall smoking-attributable DALYs in low-SDI to middle-SDI geographies between 2005 and 2015. Interpretation The pace of progress in reducing smoking prevalence has been heterogeneous across geographies, development status, and sex, and as highlighted by more recent trends, maintaining past rates of decline should not be taken for granted, especially in women and in low-SDI to middle-SDI countries. Beyond the effect of the tobacco industry and societal mores, a crucial challenge facing tobacco control initiatives is that demographic forces are poised to heighten smoking's global toll, unless progress in preventing initiation and promoting cessation can be substantially accelerated. Greater success in tobacco control is possible but requires effective, comprehensive, and adequately implemented and enforced policies, which might in turn require global and national levels of political commitment beyond what has been achieved during the past 25 years. Funding Bill & Melinda Gates Foundation and Bloomberg Philanthropies.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Socioeconomic status and smoking: a review.

            Smoking prevalence is higher among disadvantaged groups, and disadvantaged smokers may face higher exposure to tobacco's harms. Uptake may also be higher among those with low socioeconomic status (SES), and quit attempts are less likely to be successful. Studies have suggested that this may be the result of reduced social support for quitting, low motivation to quit, stronger addiction to tobacco, increased likelihood of not completing courses of pharmacotherapy or behavioral support sessions, psychological differences such as lack of self-efficacy, and tobacco industry marketing. Evidence of interventions that work among lower socioeconomic groups is sparse. Raising the price of tobacco products appears to be the tobacco control intervention with the most potential to reduce health inequalities from tobacco. Targeted cessation programs and mass media interventions can also contribute to reducing inequalities. To tackle the high prevalence of smoking among disadvantaged groups, a combination of tobacco control measures is required, and these should be delivered in conjunction with wider attempts to address inequalities in health. © 2012 New York Academy of Sciences.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              A descriptive model of the cigarette epidemic in developed countries

                Bookmark

                Author and article information

                Journal
                J Epidemiol
                J Epidemiol
                JE
                Journal of Epidemiology
                Japan Epidemiological Association
                0917-5040
                1349-9092
                5 February 2021
                4 April 2020
                2021
                : 31
                : 2
                : 145-151
                Affiliations
                [1 ]Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
                [2 ]Institute of Public Health of the American College of Greece, Athens, Greece
                [3 ]Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
                [4 ]Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
                [5 ]Istituto per lo Studio, la Prevenzione e la Rete Oncologica, Florence, Italy
                [6 ]Department of Public Health, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
                [7 ]TobaccoFree Research Institute Ireland, Dublin, Ireland
                [8 ]Agència de Salut Pública de Barcelona, Barcelona, Spain
                [9 ]CIBER en Epidemiología y Salud Pública (CIBERESP) (Biomedical Research Centre Network for Epidemiology and Public Health), Madrid, Spain
                [10 ]Institut d’investigació Biomèdica Sant Pau (IIB St. Pau), Barcelona, Spain
                [11 ]University of Stirling, Stirling, Scotland
                [12 ]University of Hamburg, Hamburg Business School, Institute for Law & Economics, Hamburg, Germany
                [13 ]Department of Primary Care and Public Health, Imperial College, London, UK
                [14 ]Tobacco Control Unit, Institut Català d’Oncologia, L’Hospitalet de Llobregat, Barcelona, Spain
                [15 ]Tobacco Control Research Unit, Institut d’Investigació Biomèdica de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain
                [16 ]Universitat de Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
                [17 ]Consortium for Biomedical Research in Respiratory Diseases (CIBER en Enfermedades Respiratorias, CIBERES), Madrid, Spain
                [18 ]Smoke Free Life Coalition, Sofia, Bulgaria
                [19 ]Universidad Politécnica de Cartagena, Cartagena, Spain
                [20 ]Instituto de Educação, Universidade do Minho, Braga, Portugal
                [21 ]Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
                [22 ]Foundation “Smart Health - Health in 3D”, Warsaw, Poland
                [23 ]Collegium Civitas, Warsaw, Poland
                [24 ]European Network for Smoking Prevention, Bruxelles, Belgium
                [25 ]Hospital Universitario La Princesa, Madrid, Spain
                [26 ]Research Institute for Evaluation and Public Policies (IRAPP), Universitat Internacional de Catalunya (UIC), Barcelona, Spain
                [27 ]DOXA Institute, Milan, Italy
                Author notes
                Address for correspondence. Silvano Gallus, ScD, Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2; 20156 Milan, Italy (e-mail: silvano.gallus@ 123456marionegri.it ).

                The full list of TackSHS investigators is provided at the end of the manuscript.

                Author information
                http://orcid.org/0000-0002-8967-0400
                http://orcid.org/0000-0002-4297-6496
                http://orcid.org/0000-0001-8620-6592
                http://orcid.org/0000-0003-2420-7922
                Article
                JE20190344
                10.2188/jea.JE20190344
                7813769
                32249267
                ec3887c1-6a8b-4653-8186-e9bde1caa301
                © 2020 Silvano Gallus et al.

                This is an open access article distributed under the terms of Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 19 December 2019
                : 21 January 2020
                Funding
                Funded by: the Ministry of Universities and Research, Government of Catalonia
                Award ID: 2017SGR139
                Funded by: the Instituto de Salud Carlos III, Government of Spain
                Award ID: INT16/00211
                Funded by: the Instituto de Salud Carlos III, Government of Spain
                Award ID: INT17/00103
                Funded by: the European Union Horizon 2020 research and innovation programme
                Award ID: 681040
                Categories
                Statistical Data
                Public Health

                tobacco,cigarette smoking,smoking prevalence,cross-sectional study,survey,europe,tackshs

                Comments

                Comment on this article